CClinicalTrials.gg
TerminatedNCT02006953Updated Jan 15, 2019

Bolus Versus Continuous Feeding Regimens Post Gastrostomy Tube Placement

An interventional study of Bolus feeding schedule following gastrostomy tube placement and Continuous chimney feeds following gastrostomy tube placement in Enteral Nutrition, Enteral Feeding and Gastrostomy Tube, sponsored by University of Michigan. Terminated at 2 sites in United States. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2019-01-15.

Sponsored by University of Michigan · Not applicable, Interventional, and Supportive care

Why this study was terminated
Difficulty recruiting due to parent declining feeding strategy
Phase
Not applicable
Study type
Interventional
Enrollment
97
Allocation
Randomized
Ages
Up to 17 Years
Sex
All
01

Study summary

The purpose of this study is to determine the best way to feed children after they have a gastrostomy tube placed. The study compares bolus feeding to continuous feeding.

Read the detailed description

This study will consist of a prospective, randomized comparison of bolus versus continuous enteral feeding protocols in pediatric patients with gastrostomy tubes

02

Conditions studied

  • Enteral Nutrition
  • Enteral Feeding
  • Gastrostomy Tube

Keywords

  • gastrostomy
  • enteral
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Less than 18 years of age
  • Admitted for gastrostomy tube placement, with or without Nissen Fundoplication

Exclusion criteria

Exclusion Criteria:

  • Immunocompromised patients
  • Short Bowel Syndrome (SBS)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
97 participants (actual)

Study arms

  • Active comparator
    Bolus

    Bolus: Total volume of feedings is determined by the amount of formula required to meet calorie and protein needs, which is determined by a Registered Dietitian. Volume of each bolus is determined by dividing the total volume of feeding by the desired number of feedings per day: If child is less than 6 months: 8 feeds/day If child is 6-12 months 6 feeds/day If child is 12 months or greater: 5 feedings/day Rate of feeds is determine by the rate needed to infuse each bolus over 1 hour. Patient to remain NPO. Once at goal, if able to take PO, may offer orally first with remainder of goal volume over the remainder of the hour.

    Procedure: Bolus feeding schedule following gastrostomy tube placement

  • Active comparator
    Continuous

    Continuous: Total volume of feedings is determined by the amount of formula required to meet calorie and protein needs, which is determined by a Registered Dietitian. Rate of feeds is determined by dividing total volume of feedings by 24 hours. Patient is to remain NPO. Once at goal, if able to take PO, may offer hourly amount orally, but only 2x per day.

    Procedure: Continuous chimney feeds following gastrostomy tube placement

Interventions

  • ProcedureBolus feeding schedule following gastrostomy tube placement
  • ProcedureContinuous chimney feeds following gastrostomy tube placement
06

What researchers measure

Primary outcomes

  1. Rate of gastrostomy tube leakage

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

Secondary outcomes

  1. Emesis

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  2. Retching

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  3. Venting beyond recommendations

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  4. Feeding changes

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  5. Unscheduled clinic/ER visits/calls

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  6. G-tube infection

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  7. Weight

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

  8. Time to goal feeds

    Symptoms are rated by parents on a daily diary for the first 4 weeks following g-tube placement, and then on a weekly diary for the next 4 weeks.

    Time frame: 8 weeks

07

Study locations

2 sites
  • University of Michigan, CS Mott Children's Hospital
    Ann Arbor, Michigan 48109, United States
  • Mercy Children's Hospital
    Toledo, Ohio 43608, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02006953
Lead sponsor
University of Michigan
Collaborators
Children's Mercy Hospital Kansas City
Responsible party
Steven W. Bruch (M.D., MSc., Clinical Associate Professor, University of Michigan) — Principal investigator
First posted
Dec 10, 2013
Start date
Aug 2011
Primary completion
Jul 18, 2018
Completion
Nov 7, 2018
Last update
Jan 15, 2019

Study contacts

Steven W Bruch, MD, MSc
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion